89 related articles for article (PubMed ID: 33785107)
1. Why does New Zealand have such poor outcomes from colorectal cancer?: the importance of the pre-diagnostic period.
Firth M; Blackmore T; Chepulis L; Keenan R; Stokes T; Elwood M; Weller D; Emery J; Lawrenson R
J Prim Health Care; 2021 Mar; 13(1):15-26. PubMed ID: 33785107
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study.
Blackmore T; Chepulis L; Rawiri K; Kidd J; Stokes T; Firth M; Elwood M; Weller D; Emery J; Lawrenson R
Fam Pract; 2022 Jul; 39(4):639-647. PubMed ID: 34871389
[TBL] [Abstract][Full Text] [Related]
3. An international comparison study of stage of colorectal cancer at diagnosis: how does New Zealand compare?
Samson P; O'Grady G; Keating J
N Z Med J; 2009 May; 122(1294):74-83. PubMed ID: 19465950
[TBL] [Abstract][Full Text] [Related]
4. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
5. Barriers and facilitators to colorectal cancer diagnosis in New Zealand: a qualitative study.
Blackmore T; Norman K; Kidd J; Cassim S; Chepulis L; Keenan R; Firth M; Jackson C; Stokes T; Weller D; Emery J; Lawrenson R
BMC Fam Pract; 2020 Oct; 21(1):206. PubMed ID: 33003999
[TBL] [Abstract][Full Text] [Related]
6. The characteristics and outcomes of patients with colorectal cancer in New Zealand, analysed by Cancer Network.
Blackmore T; Lao C; Chepulis L; Page B; Lawrenson R
N Z Med J; 2020 Apr; 133(1513):42-52. PubMed ID: 32325467
[TBL] [Abstract][Full Text] [Related]
7. A targeted promotional DVD fails to improve Māori and Pacific participation rates in the New Zealand bowel screening pilot: results from a pseudo-randomised controlled trial.
Bartholomew K; Zhou L; Crengle S; Buswell E; Buckley A; Sandiford P
BMC Public Health; 2019 Sep; 19(1):1245. PubMed ID: 31500594
[TBL] [Abstract][Full Text] [Related]
8. The New Zealand PIPER Project: colorectal cancer survival according to rurality, ethnicity and socioeconomic deprivation-results from a retrospective cohort study.
Sharples KJ; Firth MJ; Hinder VA; Hill AG; Jeffery M; Sarfati D; Brown C; Atmore C; Lawrenson RA; Reid PM; Derrett SL; Macapagal J; Keating JP; Secker AH; De Groot C; Jackson CG; Findlay MP
N Z Med J; 2018 Jun; 131(1476):24-39. PubMed ID: 29879724
[TBL] [Abstract][Full Text] [Related]
9. Prospects for population colorectal cancer screening in New Zealand.
Parry S; Richardson A; Green T; Marshall B; Bissett I; Bloomfield A; Chadwick V; Cunningham C; Findlay M; Greer B; McMenamin J; Strid J; Robertson G; Teague C
N Z Med J; 2007 Jul; 120(1258):U2633. PubMed ID: 17653251
[TBL] [Abstract][Full Text] [Related]
10. Mortality trends in Australian Aboriginal peoples and New Zealand Māori.
Phillips B; Daniels J; Woodward A; Blakely T; Taylor R; Morrell S
Popul Health Metr; 2017; 15():25. PubMed ID: 28680369
[TBL] [Abstract][Full Text] [Related]
11. Exploring Maori health worker perspectives on colorectal cancer and screening.
Pitama S; Cave T; Huria T; Lacey C; Cuddy J; Frizelle F
N Z Med J; 2012 Jun; 125(1356):75-84. PubMed ID: 22729062
[TBL] [Abstract][Full Text] [Related]
12. Pre-diagnostic routes to colorectal cancer in Central New Zealand: factors that lead to emergency presentation and longer diagnostic intervals at primary and secondary level care.
Warren M; Emery J; Krishnasamy M; O Donnell A; Gough K
J Prim Health Care; 2022 Apr; 14(1):48-56. PubMed ID: 35417325
[TBL] [Abstract][Full Text] [Related]
13. Enhancing Māori and Pasifika graduate interest in ophthalmology surgical training in New Zealand/Aotearoa: Barriers and opportunities.
Freundlich SEN; Connell CJW; McGhee CNJ; Cunningham WJ; Bedggood A; Poole P
Clin Exp Ophthalmol; 2020 Aug; 48(6):739-748. PubMed ID: 32335997
[TBL] [Abstract][Full Text] [Related]
14. Effect of ethnicity and rurality on treatment delays in patients with colorectal cancer in Northland, New Zealand.
Matthews C; Walker M; McLaughlin S; Milloy M; Harmston C
ANZ J Surg; 2021 Mar; 91(3):375-378. PubMed ID: 32869410
[TBL] [Abstract][Full Text] [Related]
15. Differences in diagnostic activity in general practice and findings for individuals invited to the danish screening programme for colorectal cancer: a population-based cohort study.
Juul JS; Andersen B; Laurberg S; Carlsen AH; Olesen F; Vedsted P
Scand J Prim Health Care; 2018 Sep; 36(3):281-290. PubMed ID: 29929415
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer characteristics and survival differences between Maori, Pacific and other New Zealand women included in the Quality Audit program of Breast Surgeons of Australia and New Zealand.
Campbell I; Scott N; Seneviratne S; Kollias J; Walters D; Taylor C; Roder D
Asian Pac J Cancer Prev; 2015; 16(6):2465-72. PubMed ID: 25824782
[TBL] [Abstract][Full Text] [Related]
17. Impact of mammographic screening on ethnic and socioeconomic inequities in breast cancer stage at diagnosis and survival in New Zealand: a cohort study.
Seneviratne S; Campbell I; Scott N; Shirley R; Lawrenson R
BMC Public Health; 2015 Jan; 15():46. PubMed ID: 25637343
[TBL] [Abstract][Full Text] [Related]
18. Burden of atrial fibrillation in Māori and Pacific people in New Zealand: a cohort study.
Gu Y; Doughty RN; Freedman B; Kennelly J; Warren J; Harwood M; Hulme R; Paltridge C; Teh R; Rolleston A; Walker N
Intern Med J; 2018 Mar; 48(3):301-309. PubMed ID: 29034985
[TBL] [Abstract][Full Text] [Related]
19. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
20. Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.
Medina-Lara A; Grigore B; Lewis R; Peters J; Price S; Landa P; Robinson S; Neal R; Hamilton W; Spencer AE
Health Technol Assess; 2020 Nov; 24(66):1-332. PubMed ID: 33252328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
